ID   Chrompho-A
AC   CVCL_X536
SY   chrompho-A
DR   Wikidata; Q54813301
RX   CelloPub=CLPUB00407;
RX   CelloPub=CLPUB00411;
RX   PubMed=7717462;
RX   PubMed=11139287;
CC   Doubling time: 51 hours (PubMed=7717462).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4146; Chromophobe renal cell carcinoma
DI   ORDO; Orphanet_319303; Chromophobe renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X537 ! Chrompho-B
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 8
//
RX   CelloPub=CLPUB00407;
RA   Krieg A.;
RT   "Characterization and functional analysis of the TRAIL system and
RT   the inhibitor of apoptosis protein (IAP) family in human neoplasia.";
RL   Thesis MD (2005); Heinrich-Heine-Universitat Dusseldorf; Dusseldorf; Germany.
//
RX   CelloPub=CLPUB00411;
RA   Petek O.;
RT   "Analysis of expression and mutation of the antimetastatic gene NM23 in
RT   human renal carcinoma cell lines and epithelioid sarcomas.";
RL   Thesis MD (2002); Heinrich-Heine-Universitat Dusseldorf; Dusseldorf; Germany.
//
RX   PubMed=7717462; PMCID=PMC1869263;
RA   Gerharz C.-D., Moll R., Storkel S., Ramp U., Hildebrandt B.,
RA   Molsberger G., Koldovsky P., Gabbert H.E.;
RT   "Establishment and characterization of two divergent cell lines
RT   derived from a human chromophobe renal cell carcinoma.";
RL   Am. J. Pathol. 146:953-962(1995).
//
RX   PubMed=11139287; DOI=10.1038/sj.cdd.4400746;
RA   Dejosez M., Ramp U., Mahotka C., Krieg A., Walczak H., Gabbert H.E.,
RA   Gerharz C.-D.;
RT   "Sensitivity to TRAIL/APO-2L-mediated apoptosis in human renal cell
RT   carcinomas and its enhancement by topotecan.";
RL   Cell Death Differ. 7:1127-1136(2000).
//